These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 35281054)
21. Not all parasites are protective. McKay DM Parasite Immunol; 2015 Jun; 37(6):324-32. PubMed ID: 25403350 [TBL] [Abstract][Full Text] [Related]
22. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF. O'Donovan AN; Herisson FM; Fouhy F; Ryan PM; Whelan D; Johnson CN; Cluzel G; Ross RP; Stanton C; Caplice NM Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H590-H603. PubMed ID: 32031871 [TBL] [Abstract][Full Text] [Related]
23. CTLA-4Ig immunotherapy of obesity-induced insulin resistance by manipulation of macrophage polarization in adipose tissues. Fujii M; Inoguchi T; Batchuluun B; Sugiyama N; Kobayashi K; Sonoda N; Takayanagi R Biochem Biophys Res Commun; 2013 Aug; 438(1):103-9. PubMed ID: 23872146 [TBL] [Abstract][Full Text] [Related]
24. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976 [TBL] [Abstract][Full Text] [Related]
25. The interplay of type 2 immunity, helminth infection and the microbiota in regulating metabolism. Moyat M; Coakley G; Harris NL Clin Transl Immunology; 2019; 8(11):e01089. PubMed ID: 31719981 [TBL] [Abstract][Full Text] [Related]
26. Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota. Janssen AWF; Katiraei S; Bartosinska B; Eberhard D; Willems van Dijk K; Kersten S Diabetologia; 2018 Jun; 61(6):1447-1458. PubMed ID: 29502266 [TBL] [Abstract][Full Text] [Related]
27. Ectopic fat deposition and global cardiometabolic risk: new paradigm in cardiovascular medicine. Shimabukuro M; Kozuka C; Taira S; Yabiku K; Dagvasumberel M; Ishida M; Matsumoto S; Yagi S; Fukuda D; Yamakawa K; Higa M; Soeki T; Yoshida H; Masuzaki H; Sata M J Med Invest; 2013; 60(1-2):1-14. PubMed ID: 23614905 [TBL] [Abstract][Full Text] [Related]
28. Trichinella spiralis infection ameliorated diet-induced obesity model in mice. Kang SA; Choi JH; Baek KW; Lee DI; Jeong MJ; Yu HS Int J Parasitol; 2021 Jan; 51(1):63-71. PubMed ID: 32966835 [TBL] [Abstract][Full Text] [Related]
30. Glucoraphanin Ameliorates Obesity and Insulin Resistance Through Adipose Tissue Browning and Reduction of Metabolic Endotoxemia in Mice. Nagata N; Xu L; Kohno S; Ushida Y; Aoki Y; Umeda R; Fuke N; Zhuge F; Ni Y; Nagashimada M; Takahashi C; Suganuma H; Kaneko S; Ota T Diabetes; 2017 May; 66(5):1222-1236. PubMed ID: 28209760 [TBL] [Abstract][Full Text] [Related]
31. Metabolic syndrome, insulin resistance and systemic inflammation as risk factors for reduced lung function in Korean nonsmoking males. Lim SY; Rhee EJ; Sung KC J Korean Med Sci; 2010 Oct; 25(10):1480-6. PubMed ID: 20890430 [TBL] [Abstract][Full Text] [Related]
33. Clinical and Body Compositional Factors Associated with Metabolic Syndrome in Obese Koreans: A Cross-Sectional Study. Kim YM; Kim S; Kim SH; Won YJ Metab Syndr Relat Disord; 2018 Aug; 16(6):290-298. PubMed ID: 29717940 [TBL] [Abstract][Full Text] [Related]
34. Prebiotics in the management of components of the metabolic syndrome. O'Connor S; Chouinard-Castonguay S; Gagnon C; Rudkowska I Maturitas; 2017 Oct; 104():11-18. PubMed ID: 28923170 [TBL] [Abstract][Full Text] [Related]
35. The Effects of Kim M; Seol MH; Lee BC Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212747 [TBL] [Abstract][Full Text] [Related]
36. Lee E; Jung SR; Lee SY; Lee NK; Paik HD; Lim SI Nutrients; 2018 May; 10(5):. PubMed ID: 29783731 [TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor 3 ablation prevented high-fat diet-induced obesity and metabolic disorder. Zhang G; Li R; Li W; Yang S; Sun Q; Yin H; Wang C; Hou B; Wang H; Yu L; Chen R; Shi L; Zhang K; Liew CW; Qiang G; Sun Q; Liu C J Nutr Biochem; 2021 Sep; 95():108761. PubMed ID: 33965533 [TBL] [Abstract][Full Text] [Related]
38. [The role of peroxisome proliferator-activated receptors γ (PPARγ) in obesity and insulin resistance]. Chmielewska-Kassassir M; Woźniak LA; Ogrodniczek P; Wójcik M Postepy Hig Med Dosw (Online); 2013 Dec; 67():1283-99. PubMed ID: 24379269 [TBL] [Abstract][Full Text] [Related]
39. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Fahed G; Aoun L; Bou Zerdan M; Allam S; Bou Zerdan M; Bouferraa Y; Assi HI Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054972 [TBL] [Abstract][Full Text] [Related]
40. Cell Type-Specific Immunomodulation Induced by Helminthes: Effect on Metainflammation, Insulin Resistance and Type-2 Diabetes. Aravindhan V; Anand G Am J Trop Med Hyg; 2017 Dec; 97(6):1650-1661. PubMed ID: 29141759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]